GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guizhou Yibai Pharmaceutical Co Ltd (SHSE:600594) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Guizhou Yibai Pharmaceutical Co (SHSE:600594) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 12, 2025)


View and export this data going back to 2004. Start your Free Trial

What is Guizhou Yibai Pharmaceutical Co Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Guizhou Yibai Pharmaceutical Co's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of Guizhou Yibai Pharmaceutical Co's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Guizhou Yibai Pharmaceutical Co's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Guizhou Yibai Pharmaceutical Co's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Guizhou Yibai Pharmaceutical Co's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Guizhou Yibai Pharmaceutical Co's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

Guizhou Yibai Pharmaceutical Co  (SHSE:600594) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Guizhou Yibai Pharmaceutical Co Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Guizhou Yibai Pharmaceutical Co's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Guizhou Yibai Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guizhou Yibai Pharmaceutical Co Ltd (SHSE:600594) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
SZSE:000153 SZSE:002940 SHSE:603079 SZSE:002107 SHSE:600080 SZSE:301331 SZSE:300534 SHSE:600568 SZSE:300452 SHSE:603811 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
N/A
Address
No. 220-1 Baiyun Avenue, Guiyang, Guizhou, CHN, 550008
Website
http://www.gzcci.com
Guizhou Yibai Pharmaceutical Co Ltd engages in the research, development, production, and sale of pharmaceutical products in China. Its products include tumor, cardio-cerebral vascular, respiratory system, anti-rheumatic, digestive system, pediatric, gynecological, andrological, anti-infection, anti-inflammatory, analgesic, tonic, and other drugs.
Executives
Dou Qi Ling Director
Gan Ning Director
Lang Hong Ping Director
Xia Xiao Hui senior management
Dou Ya Qi Director
Wang Zhi Wei Director
Zhu Yue Xing Director
Dai Yuan Fu senior management
Zhang Sheng Gui senior management
Feng Zhi Gang senior management
Yue Wei Director
Liu Hua Supervisors
Ye Xiang Wu Director
Jian Wei Guang Director

Guizhou Yibai Pharmaceutical Co Headlines

No Headlines